康诺生物制药股份有限公司向港交所提交上市申请书

Group 1 - The core point of the article is that Connaught BioPharma Co., Ltd. has submitted a listing application to the Hong Kong Stock Exchange [1] Group 2 - The submission of the listing application indicates the company's intention to raise capital through public markets [1] - This move may reflect the company's growth strategy and potential expansion plans in the biopharmaceutical sector [1] - The listing could provide the company with increased visibility and credibility in the industry [1]